Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds Medical XpressHalf of advanced melanoma patients live for 10 years with double drug treatment The GuardianNew skin cancer treatment helps patients live 10 years after diagnosis, study finds The TelegraphImmunotherapy Drugs Extend Survival for Patients With Advanced Melanomas U.S. News & World ReportNeoadjuvant Immunotherapy Superior to Targeted Therapy in Stage III Melanoma AJMC.com Managed Markets Network